Publications by authors named "Lianpan Dai"

Claim this Profile
P
Pulmonary Surfactant Protein-Hitchhiking Inhalable Vaccines Augment Mucosal and Systemic Antiviral Immunity.
Mengyu Guo, Jiufeng Sun, Yuecong Guo, Ziwei Chen, Susu Gao, Lianpan Dai

ACS Nano· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multivalent mpox protein nanoparticle vaccines confer cross-protection against orthopoxvirus infection.
Lijun Zhang, Chuanyu Liu, Chenxi Yang, Xueqi Xiao, Senyu Xu, Lianpan Dai

PLoS Pathog· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A SARS-CoV and SARS-CoV-2 RBD Heterodimer Vaccine Candidate.
Rong Zhang, Dedong Li, Pengyue Gao, Wenjing Ruan, Shitong Qiao, Lianpan Dai

J Med Virol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Approach from the laboratory to the field: New strategies in the control of mosquito-borne infectious diseases.
Ziqian Xu, Lianpan Dai, Jun Liu

Sci China Life Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protective RBD-dimer vaccines against SARS-CoV-2 and its variants produced in glycoengineered Pichia pastoris.
Tongxin Zhao, Sheng Liu, Pengyan Wang, Yanfang Zhang, Xinrui Kang, Lianpan Dai

PLoS Pathog· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies.
Qingwen He, Yaling An, Xuemei Zhou, Haitang Xie, Lifeng Tao, Lianpan Dai

Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mosaic RBD nanoparticle elicits immunodominant antibody responses across sarbecoviruses.
Chuanyu Liu, Senyu Xu, Yuxuan Zheng, Yufeng Xie, Kun Xu, Lianpan Dai

Cell Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Injectable Hydrogel Mucosal Vaccine Elicits Protective Immunity against Respiratory Viruses.
Wenjiao Fu, Mengyu Guo, Xuemei Zhou, Zhenzhen Wang, Jiufeng Sun, Lianpan Dai

ACS Nano· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine.
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai

Signal Transduct Target Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5.
Minrun Duan, Huixin Duan, Yaling An, Tianyi Zheng, Shengfeng Wan, Lianpan Dai

Emerg Microbes Infect· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatially resolved transcriptomics reveals distinct pulmonary immune responses during influenza virus and SARS-CoV-2 infections.
Min Zhao, Fei Shao, Zhen Liu, Jiangwen Ma, Dou Yu, Lianpan Dai

Sci Bull (Beijing)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine.
Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai

Signal Transduct Target Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.
Xia Rao, Runchu Zhao, Zhou Tong, Shuxin Guo, Weiyu Peng, Lianpan Dai

Proc Natl Acad Sci U S A· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad protective RBD heterotrimer vaccines neutralize SARS-CoV-2 including Omicron sub-variants XBB/BQ.1.1/BF.7.
Yanfang Zhang, Xinrui Kang, Sheng Liu, Pu Han, Wenwen Lei, Lianpan Dai

PLoS Pathog· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron neutralisation: RBD-dimer booster versus BF.7 and BA.5.2 breakthrough infection.
Lianpan Dai, Huixin Duan, Xueyuan Liu, Huan Zhou, Minrun Duan

Lancet· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19.
Yaling An, Gan Zhao, Huixin Duan, Ning Zhang, Minrun Duan, Lianpan Dai

J Med Virol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine.
Shuxin Guo, Yuxuan Zheng, Zhengrong Gao, Minrun Duan, Sheng Liu, Lianpan Dai

Cell Discov· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inside-out assembly of viral antigens for the enhanced vaccination.
Fengqiang Cao, Sha Peng, Yaling An, Kun Xu, Tianyi Zheng, Lianpan Dai

Signal Transduct Target Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developmental and reproductive toxicity of a recombinant protein subunit COVID-19 vaccine (ZF2001) in rats.
Yisheng Song, Jinjin Shao, Guangbiao She, Wanqiang Lv, Guoyu Chen, Lianpan Dai

NPJ Vaccines· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3-17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial.
Lidong Gao, Yan Li, Peng He, Zhen Chen, Huaiyu Yang, Lianpan Dai

Lancet Child Adolesc Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of adjuvanting RBD-dimer-based subunit COVID-19 vaccines with Sepivac SWE™.
Senyu Xu, Huixin Duan, Yaling An, Xiyue Jin, Minrun Duan, Lianpan Dai

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.
Qian Chen, Pei Du, Yuxuan Han, Xuehui Ma, Rong Zhang, Lianpan Dai

Biosaf Health· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Toxicity and Immunogenicity of a COVID-19 Vaccine (ZF2001) in Cynomolgus Monkeys.
Hongzhong Yang, Wei Pan, Guoyu Chen, Enqi Huang, Qijiong Lu, Lianpan Dai

Vaccines (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccines expressing homo-prototype/Omicron and hetero-chimeric RBD-dimers against SARS-CoV-2.
Yuxuan Han, Yaling An, Qian Chen, Kun Xu, Xueyuan Liu, Lianpan Dai

Cell Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus.
Yan Li, Zhihai Chen, Lili Wu, Lianpan Dai, Jianxun Qi

Innovation (Camb)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis